FRZB and neoplasm: When examining specific primary tumor sites (lung, pancreas, small intestine, duodenum, stomach, rectum), there were no significant differences in LRP6 (p = 0.333) and SFRP3 (p = 0.154) concentrations, but DVL1 results showed significant variation (p < 0.01).